10x Genomics (TXG) Invested Capital (2018 - 2019)

10x Genomics (TXG) posted Invested Capital of $9.9 million for Q4 2019, up 33.85% sequentially from $7.4 million in Q3 2019, and up 136.02% YoY from $4.2 million in Q4 2018.

10x Genomics (TXG) Invested Capital (2018 - 2019) Analysis & Trends

10x Genomics has reported Invested Capital for 2 years, with the latest figure at $9.9 million in Q4 2019.

  • Quarterly Invested Capital rose 136.02% year-over-year to $9.9 million in Q4 2019, while the trailing twelve-month figure through Sep 2020 was $9.9 million (down 14.59% YoY) and the FY2019 annual result came in at $9.9 million, up 136.02% from the prior year.
  • Invested Capital climbed to $9.9 million in Q4 2019 per TXG's latest filing, from $7.4 million in the prior quarter.
  • Over five years, Invested Capital peaked at $9.9 million in Q4 2019 and troughed at $4.2 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 41.45 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn -
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 14.19 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Privia Health 2.78 Bn 2.42 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 9.88 Mn
Sep 30, 2019 7.38 Mn
Dec 31, 2018 4.19 Mn